Prevalence of infection with the hepatitis B and C viruses and the human immunodeficiency virus in 39 Maroccan children with hemophilia;Prevalence des hepatites virales B et C et du VIH chez 39 enfants hemophiles Marocains

Annales de Pediatrie

Volumn 46, Issue 3, 1999, Pages 199-204

  Bousfiha, A A ^a   Hachim, J ^a   Benjelloun, S ^b   Benslimane, A ^b   Mikou, N ^a   Hadj Khalifa, H ^a  

^a Hopital d'Enfants   (Morocco)

^b Institut Pasteur du Maroc   (Morocco)

Author keywords

Contamination; Hemophilia; Hepatitis B and C; HIV; Pediatric patient

Indexed keywords

AMINOTRANSFERASE; FRESH FROZEN PLASMA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE MARKER; DISEASE TRANSMISSION; HEMOPHILIA; HUMAN; INFANT; MORBIDITY; MORTALITY; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0032975031     PISSN: 00662097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. GAZENGEL C., ROTHSCHILD Ch. Hémophilie et son traitement. Encycl Med Chir, Hématologie-Maladies infectieuses, 2400, 1992.
2. LAURIAN Y., DOMMERGUES J.P., TCHERNIA G. - L'enfant hémophile. Encycl Med Chir, Pédiatrie, 4080 B20, 1990.
3. FIMBEL B., LAURIAN Y., CHAMBOST H., DURIN A., BOYELDIEN D., BERTHIER A.M., PARQUET A., GUEROIS C. - Haemophilia and hepatitis C: comparative study of transaminase levels and specific HVC antibodies in French affected children. Rapport du congrès de la Fédération mondiale des hémophiles, 1994, 132.
4. GONDRE C. - Prévalence et incidence des hépatites virales B et C et des infections par le VIH chez les hémophiles de la région du centre. Thèse Med́ Tours, 1990, no 9.
5. MICHEL ML, TIOLLAIS P. - Structure and expression of the hepatitis B virus genome. Hepatology, 1987, 7, 615-635.
6. BRENNER B., SCHWARTZ S. - The prevalence and interaction of human immunodeficiency virus and hepatitis B virus in Israeli hemophiliacs. Isr J Med Sci, 1991, 27, 10, 557-561.
7. ESSAADI M., HARIF M., QUESSAR A., TRACHLI A., BENCHEKROUN S., BENCHEMSIN. - La contamination virale dans l'hémiophilic, étude de 40 cas. Rev Mar Med Santé, 1993, 15, 2, 21-27.
8. GUZMAN V.E., BRAVO L.A. - Seroprevalence of HIV, HCV, AgHBs, in patients hemophiliacs. Rapport du congrès de la Fédération mondiale des hémophiles 1994, 310.
9. LESLIE DE., RANN S., NICHOLSON S., FAIRELY C.K., GUST I.D. - Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease. Med J Aust, 1992, 156, 11, 789-792.
10. SONI P.N., TAIT D.R., KENOYER D.G., FERNANDES-COSTA F., NAICKER S., GOPAUL W., SIMJEE A.E. - Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol, 1993, 40-1, 65-68.
11. BRENNER B., BACK D. - Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients. Isr. J Med Sci, 1944, 30, 12, 886-890.
12. CECCONI N., CARDUCCI A., SCASSO A., PANICUCCI F. -HVB and HVC serology in italian HIV- and HIV- haemophiliacs. Rapport du congrés de la Fédération mondiale des hémophiles, 1994, 306.
13. CHOUIKHA M., BAHRI M., AMOR A., NOOMAN S.~ Fréqucnce de l'antigène HBs et de l'anticorps anti-HTLV1 dans une population de 43 hémophiles. Tunis Med, 1987, 65, 473-475.
14. ROISI C.L., HILLINGER F.B., HOOTS W.K., CONTANT C., GILL J., RAGNI M., PARMLEY R., SEXAUER C. GOMPERTS E., BUCHANAN G. - A multicenter study of viral hepatitis in a United States hemophilic population. Blood, 1993, 81, 2, 412-418.
15. GUEROIS C., PARQUET A., VICARIOT M., LECOEUR FF., MAISONNEUVE P., COUROUCE A.M., DUBOIS F., LAURIAN Y. - Efficacité de l'inactivation virale des concentrés de facteur VIII et IX par procédé solvant-détergent. Evaluation chez l'hémophile. Presse Med, 1991, 20, 25, 1163-1166.
16. MARICIS M., PRESTON F.E., TRIGER D.R., UNDERWOOD J.C., WESTLAKE L., ADELMAN M.I. - A randomised controlled trial of recombinant interferon-alpha in chronic hepatitis in hemophiliacs. Blood, 1991, 78, 1672-1677.
17. MANUCCI P.M., SCHIMPF K. - Low risk for hepalitus C in hemophiliacs given a high-purity, pasteurised factor VIII concentrate. An Intern Med, 1990, 111, 27-32.
18. BHATTACHARYA D.K., BHATTACHARYEE S., DE M., LAHIRI P. - Prevalence of hepatitis C in transfusion dependent thalassaemics and haemophilics. Indian J Med Res, 1991, 94, 430-432.
19. NAKATA S., SONG P. - Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol, 1994, 9, 4, 416-419.
20. BAHAKIM H., BAKIR T.M., ARIF M., RAMIA S. - Hepatitis C antibodies in high-risk Saudi groups. Vox Sang, 1991, 60, 3, 162-164.
21. ZAHRAOUI M. - Hépatites virales: Epidémiologie. Bulletin Société Marocaine des Sciences Médicales, 1996, 7, 1, 7-12.
22. ARONIS S., ARAPINIS C. - C viraemie in infected heamophilic children through factor concentrates. Rapport du congrès de la Fédération mondiale des hémophiles, 1994, 302.
23. MORFINI M., MANNUCCI P.M. - Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation. Vox Sang, 1994, 67, 2, 178-182.
24. TEDDER R.S., BRIGGS M., RING C., TUKE P.W., JONES P., SAVIDGE G.F., RODGERS B., GARSON J.A. - Hepatitis C antibody profile and viraemia prevalence in adults with severe haemopma.Br J Haematol, 1991, 79, 3, 512-515.
25. WIDELL A., HANSSON B.C., BERNTOP E., MOERTRUP T., JOHANSSON H.P., HANSSON H., NORDENFELT E. -Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B. Scand J Infect Dis, 1991, 23, 1, 19.
26. BLANCHETTE V.S., VORSTMAN E., SHOR A., WANG E., PETRIC M., JETT B.W., ALTER H.J. - Hepatitic C infection in children with hemophilia A and B. Blood, 1991, 78, 2, 285-289.
27. MAUSER-BUNSCHOTEN E.P., BRESTERS D. - Hepatitis C infection and viremia in Dutch hemophilia patients. Rapport du congrès de la Fédération mondiale des hémophiles, 1994, 129.
28. ARTEAGA-VISCAINO M., BLITZ-DORFMAN L., ECHEVERRIA JM, LEON P., WEIR-MEDINA J., DIEZ-EWALD M., VIZCAINO G., TORRES E., PORTO-ESPINOZAL. - Hepatitis C in hemophiliac patients in Maracaibo, Venezuela.
29. EKERT H., EKERT N.L. - Haemophilia. A management in Victorian, New South Wales Australian haemophilia centres. Med J. Aust, 1995, 162, 11, 569-571.
30. JACKSON S.R., CARTER J.M. - Hepatitis C seroprevalence in bone marrow transplant recipients and haemophiliacs. N Z Med J, 1994, 107, 970, 1-11.
31. WAGNER N., ROTTHAUWE H.W. - Hepatitis C contributes to liver disease in children and adolescents with hemophilia. Klin Pediatr. 1994, 206, 1, 40-44.
32. ZENZ W., SHOFMANN H., MUNTEAN W. - Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders. Wien Klin Wockenschr. 1991, 103, 3, 69-72.
33. BUFFET C. - Marqueurs biologiques sériques et dépistage des hépatites virales. Rev Prat, 1995, 45, 168-173.
34. LAURIAN Y. - In: SCHAISON G., Hématologie de l'enfant. Deuxième édition. pp. 468-475, Paris, Flammarion, 1995.
35. YAZID M. - Infections par les virus des hepatites B et C dans les hépatopathies chroniques (cirrhose et carcinome hépatocellulaire). These Méd Casa, 1995, no 225.
36. KIYOSAWA K., AKAHANEY Y., NAGATA A., FURUTA S. -Hepatocellular carcinoma after non A, non B post-transfusion hepatitis. Ann J Gastrenterol, 1984, 79, 777-781.
37. BLUMBERG B.S., ALTER H.J., VISHCH S. - A new antigen in leukemia sera. J Amer Med Ass. 1965, 191, 541-546.
38. DAVIS G.L. - Recombinant alpha interferon treatment of non A, non B (type C) hepatitis: review of studies and recommendation for treatment. J Hepatol, 1990, 11, 572-577.
39. ZARSKI JP, COHARD M. - Hépatite C. Rev Prat, 1995, 45, 180-184.
40. ISOBE K., IMOTO M., FUKRUDA Y. - Hepatitis C virus infection and genotypes in Japanese haemophiliacs. Liver, 1995, 15, 3, 131-134.
41. EVANS J.A., PASI K.J., WLLIAMS M.D., HILL F.G. -Consistently normal CD4+, CD8+ levels in haemophiliac boys only treated with a virally safe factor VIII concentrate (BPL8Y). Br J Haematol, 1991, 79, 3, 457-461.
42. PERRET B.A., MORELL A., BUTHER-BRUNNER E., BURCKHARDT J.J. - No HCV serocomersion in hemophilia following substitution with virus-inactived coagulation factor VIII and IX concentrates. Schweiz Med Wochenschr. 1991, 121, 44, 1621-1623.
43. PISTELLO M., CECCHERNI-NELLI L., CECCONI N., BENDINELLI M., PANICUCCI F. - Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus inactivated concentrates: five years follow-up and correlation with antibodies to other viruses. J Med Virol, 1991, 33, 1, 43-46.